Data collection infrastructure for patient outcomes in the UK – opportunities and challenges for cell and gene therapies launching

by Jesper Jørgensen, Laura Mungapen, Panos Kefalas
Published 2019-01-01

Establishing the cost of implementing a performance-based, managed entry agreement for a hypothetical CAR T-cell therapy

by Panos Kefalas, Omar Ali, Jesper Jørgensen, Nick Merryfield, Tim Richardson, Adam Meads, Laura Mungapen, Matthew Durdy
Published 2018-01-01